Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary A Ulaner

Showing results (61-70 of 152) with videos related to

Pageof 16
Sort By:
Endocrinology|September 10, 2003
CTCF binding at the insulin-like growth factor-II (IGF2)/H19 imprinting control region is insufficient to regulate IGF2/H19 expression in human tissuesGary A Ulaner, Youwen Yang, Ji-Fan Hu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 3, 2016
Molecular Imaging of Biomarkers in Breast CancerGary A Ulaner, Chris C Riedl, Maura N Dickler, et al.
Clinical Nuclear Medicine|July 14, 2020
Extramedullary Myeloma of the Uterus on 18F-FDG PET/CT: A Rare Manifestation of Multiple MyelomaPamela Ines Causa Andrieu, Jeeban Paul Das, Sungmin Woo, et al.
PET Clinics|June 27, 2023
Metabolic Positron Emission Tomography in Breast CancerKatherine Cecil, Laura Huppert, Rita Mukhtar, et al.
Medicine|February 3, 2018
Specialized second-opinion radiology review of PET/CT examinations for patients with diffuse large B-cell lymphoma impacts patient care and managementPeter Sawan, Karim Rebeiz, Heiko Schoder, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 19, 2020
Head-to-Head Evaluation of <sup>18</sup>F-FES and <sup>18</sup>F-FDG PET/CT in Metastatic Invasive Lobular Breast CancerGary A Ulaner, Komal Jhaveri, Sarat Chandarlapaty, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 4, 2006
Visualization of telomerase reverse transcriptase (hTERT) promoter activity using a trimodality fusion reporter constructParasuraman Padmanabhan, Jesse Otero, Pritha Ray, et al.
American Journal of Nuclear Medicine and Molecular Imaging|May 18, 2016
Prognostic value of FDG PET/CT-based metabolic tumor volumes in metastatic triple negative breast cancer patientsBrett Marinelli, Carina Espinet-Col, Gary A Ulaner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 19, 2016
Prospective Clinical Trial of <sup>18</sup>F-Fluciclovine PET/CT for Determining the Response to Neoadjuvant Therapy in Invasive Ductal and Invasive Lobular Breast CancersGary A Ulaner, Debra A Goldman, Adriana Corben, et al.
Journal of Cellular Biochemistry|November 19, 2003
Epigenetic regulation of Igf2/H19 imprinting at CTCF insulator binding sitesYouwen Yang, Ji-Fan Hu, Gary A Ulaner, et al.
Pageof 16

Showing results (61-70 of 152) with videos related to

Sort By:
Pageof 16
Endocrinology|September 10, 2003
CTCF binding at the insulin-like growth factor-II (IGF2)/H19 imprinting control region is insufficient to regulate IGF2/H19 expression in human tissuesGary A Ulaner, Youwen Yang, Ji-Fan Hu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 3, 2016
Molecular Imaging of Biomarkers in Breast CancerGary A Ulaner, Chris C Riedl, Maura N Dickler, et al.
Clinical Nuclear Medicine|July 14, 2020
Extramedullary Myeloma of the Uterus on 18F-FDG PET/CT: A Rare Manifestation of Multiple MyelomaPamela Ines Causa Andrieu, Jeeban Paul Das, Sungmin Woo, et al.
PET Clinics|June 27, 2023
Metabolic Positron Emission Tomography in Breast CancerKatherine Cecil, Laura Huppert, Rita Mukhtar, et al.
Medicine|February 3, 2018
Specialized second-opinion radiology review of PET/CT examinations for patients with diffuse large B-cell lymphoma impacts patient care and managementPeter Sawan, Karim Rebeiz, Heiko Schoder, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 19, 2020
Head-to-Head Evaluation of <sup>18</sup>F-FES and <sup>18</sup>F-FDG PET/CT in Metastatic Invasive Lobular Breast CancerGary A Ulaner, Komal Jhaveri, Sarat Chandarlapaty, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 4, 2006
Visualization of telomerase reverse transcriptase (hTERT) promoter activity using a trimodality fusion reporter constructParasuraman Padmanabhan, Jesse Otero, Pritha Ray, et al.
American Journal of Nuclear Medicine and Molecular Imaging|May 18, 2016
Prognostic value of FDG PET/CT-based metabolic tumor volumes in metastatic triple negative breast cancer patientsBrett Marinelli, Carina Espinet-Col, Gary A Ulaner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 19, 2016
Prospective Clinical Trial of <sup>18</sup>F-Fluciclovine PET/CT for Determining the Response to Neoadjuvant Therapy in Invasive Ductal and Invasive Lobular Breast CancersGary A Ulaner, Debra A Goldman, Adriana Corben, et al.
Journal of Cellular Biochemistry|November 19, 2003
Epigenetic regulation of Igf2/H19 imprinting at CTCF insulator binding sitesYouwen Yang, Ji-Fan Hu, Gary A Ulaner, et al.
Pageof 16